Advice for the use of the multicomponent meningococcal serogroup B (4CMenB) vaccine :: HP40-104/2014E-PDF
an Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI)
|Department/Agency||Public Health Agency of Canada.|
|Title||Advice for the use of the multicomponent meningococcal serogroup B (4CMenB) vaccine :|
|Subtitle||an Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI)|
|Other Language Editions||[French]|
|Electronic Document|| |
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact the authoring department to request a format other than those available.
We invite you to consult the Frequently Asked Questions page for additional information regarding the Archived Content notice.
Note: The URLs contained in this/these document(s) may no longer be functional
|Number of Pages||43p.|
|Departmental Catalogue Number||Pub.: 140012|
- Date modified: